Crossmark

Methods and efficacy of extracellular vesicles derived from mesenchymal stromal cells in animal models of disease: a preclinical systematic review protocol

Crossref DOI link: https://doi.org/10.1186/s13643-019-1242-y

Published Online: 2019-12-12

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tieu, Alvin

Slobodian, Mitchell

Fergusson, Dean A.

Montroy, Joshua

Burger, Dylan

Stewart, Duncan J.

Shorr, Risa

Allan, David S. https://orcid.org/0000-0003-3261-8289
Lalu, Manoj M. https://orcid.org/0000-0002-0322-382X
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-12
More Information

Article History

Received: 20 March 2019

Accepted: 24 November 2019

First Online: 12 December 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: DJS is President and CEO of Northern Therapeutics (Montreal, QC, Canada). The remaining authors have no competing interests to declare.

Document is current

Any future updates will be listed below